It’s a major milestone for Micro-X (ASX:MX1), which noted the ASA had submitted a request for ethics approval to start the trials. Meanwhile final site approvals and regulatory licences are in process ...
Data from project, including technical file and clinical evaluation report, to be collected to support integration into ambulances following regulatory approval Adelaide-based Micro-X (ASX:MX1) said ...
Micro-X has captured the first human images using its carbon nanotube Cone Beam CT technology as a pilot study gets underway at Royal Melbourne Hospital. First patient images were taken at Royal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results